ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,718.57
      0.28%
      US Tech 100
      19,326.40
      0.02%
      Dow Jones
      42,124.65
      0.00%
      Brent Oil
      75.015
      1.74%
      Bitcoin
      63,592.56
      0.42%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Eterna Therapeutics Inc (ERNA) Quote

      Eterna Therapeutics Inc

      Eterna Therapeutics Inc (ERNA)

      Is $ul-sh Bd A
      1.22
      -0.06
      (-4.69%)
      Closed September 23 4:00PM
      Delayed by 15 minutes
      1.22
      0.00
      ( 0.00% )
      Pre Market: 4:14AM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      1.22
      Bid
      0.91
      Ask
      1.62
      Volume
      -
      0.00 Day's Range 0.00
      0.840101 52 Week Range 2.625
      Market Cap
      6.601M
      Previous Close
      1.22
      Open
      -
      Last Trade
      Last Trade Time
      -
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      8,797
      Shares Outstanding
      5,410,588
      Dividend Yield
      -
      PE Ratio
      -0.30
      Earnings Per Share (EPS)
      -4.01
      Revenue
      68k
      Net Profit
      -21.68M

      About Eterna Therapeutics Inc

      Eterna Therapeutics Inc is a biopharmaceutical company. The company develops transformational new medicines using advanced cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indicati... Eterna Therapeutics Inc is a biopharmaceutical company. The company develops transformational new medicines using advanced cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. With its strategic partners, the group is developing nucleic acid and cell therapies that can significantly improve the health outcomes of patients with high unmet medical needs. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Television Broadcast Station
      Website
      eternatx.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      2022
      Eterna Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ERNA. The last closing price for Eterna Therapeutics was $1.22. Over the last year, Eterna Therapeutics shares have traded in a share price range of $ 0.840101 to $ 2.625.

      Eterna Therapeutics currently has 5,410,588 shares outstanding. The market capitalization of Eterna Therapeutics is $6.60 million. Eterna Therapeutics has a price to earnings ratio (PE ratio) of -0.30.

      Ask ADVFN Intelligence (AI)

      ERNA Latest News

      More News

      Form 8-K - Current report

      15 hours ago
      Edgar (US Regulatory)

      Form 8-K - Current report

      August 19 2024
      Edgar (US Regulatory)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      August 13 2024
      Edgar (US Regulatory)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      May 14 2024
      Edgar (US Regulatory)

      Eterna Therapeutics to Present at the ASGCT 27th Annual Meeting on Development of Beta 2 Microglobulin-Knockout (B2M-KO) iMSC Line with Enhanced Immunosuppressive Activity and Stealthing Features that May Further Augment the Therapeutic Potential of MSCs i

      The presentation reports the development of a beta 2 microglobulin-knockout (B2M-KO) iMSC line with enhanced immunosuppressive activity and stealthing features that may further augment the...

      May 10 2024
      GlobeNewswire Inc.

      Eterna Therapeutics Announces Appointment of Mahendra Rao, PhD, to its Scientific Advisory Board

      CAMBRIDGE, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”), a preclinical-stage biopharmaceutical company, committed to realizing the...

      May 08 2024
      GlobeNewswire Inc.

      Eterna Therapeutics to Present at the ASGCT 27th Annual Meeting on the Development of a mRNA-Engineered iPSC Line which Mimics Native B2M Expression, via Targeted Insertion of HLA-E at the B2M Locus

      Eterna reports the development of an mRNA-engineered iPSC line developed using UltraSlice™ to express a B2M-HLA-E fusion transgene in lieu of the endogenous B2M gene product to mimic native B2M...

      May 07 2024
      GlobeNewswire Inc.

      Eterna Therapeutics Announces the Appointment of Peter Cicala, JD, to its Board of Directors

      CAMBRIDGE, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”), a life science company committed to realizing the potential of mRNA cell...

      February 20 2024
      GlobeNewswire Inc.

      Form 3 - Initial statement of beneficial ownership of securities

      February 16 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.27-18.12080536911.491.491.2147871.29357268CS
      4-0.58-32.22222222221.81.911.290861.48515771CS
      12-0.68-35.78947368421.92.6251.287971.76004828CS
      26-1.21-49.79423868312.432.6251.277851.90120706CS
      52-0.8-39.6039603962.022.6250.840101149471.60474615CS
      156-2.98-70.95238095244.27.150.840101321573.67041147CS
      260-2.98-70.95238095244.27.150.840101321573.67041147CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      MSSMaison Solutions Inc
      $ 1.51
      (111.19%)
      		5.14M
      TRNRInteractive Strength Inc
      $ 0.3977
      (68.30%)
      		5.72M
      HSCSHeart Test Laboratories Inc
      $ 4.65
      (58.16%)
      		3.24M
      GBNYGenerations Bancorp NY Inc
      $ 15.64
      (42.18%)
      		129.78k
      MLGOMicroAlgo Inc
      $ 0.2621
      (32.11%)
      		32.37M
      BIVIBioVie Inc
      $ 1.28
      (-54.29%)
      		129.35k
      GHSIGuardion Health Sciences Inc
      $ 5.77
      (-45.15%)
      		2.71k
      TOIIWOncology Institute Inc
      $ 0.014
      (-25.13%)
      		23k
      LNWLight and Wonder Inc
      $ 93.30
      (-17.20%)
      		2.79k
      FRESFresh2 Group Ltd
      $ 1.52
      (-16.48%)
      		21.75k
      MLGOMicroAlgo Inc
      $ 0.2621
      (32.11%)
      		32.37M
      TRNRInteractive Strength Inc
      $ 0.3977
      (68.30%)
      		5.72M
      MSSMaison Solutions Inc
      $ 1.51
      (111.19%)
      		5.14M
      NUKKNukkleus Inc
      $ 0.27
      (7.36%)
      		3.26M
      HSCSHeart Test Laboratories Inc
      $ 4.65
      (58.16%)
      		3.24M

      Discussion

      View Full Feed
      williams45 williams45 3 minutes ago
      $XXII has overlooked potential & a sweet price!
      https://www.nasdaq.com/market-activity/stocks/xxii
      XXII
      Debunkinator Debunkinator 3 minutes ago
      $ASII Bid sitting about to come to an end--Lace them shoe's up😉 Chase is on 🩰
      ASII
      arachnodude arachnodude 3 minutes ago
      BSLK
      BSLK
      PENNIEStoSTACKS PENNIEStoSTACKS 4 minutes ago
      $MLGO CHART

      www.stockscores.com/chart.asp?TickerSymbol=mlgo%20&TimeRange=90&Interval=d&Volume=None&ChartType=CandleStick&Stockscores=None&ChartWidth=1100&ChartHeight=480&LogScale=None&Band=None&avgType1=SMA&movAvg1=50&avgType2=SMA&movAvg2=100&Indicator1=RSI&Indicator2=AccDist&Indicato
      MLGO MNTS
      MartinLutherKing MartinLutherKing 5 minutes ago
      POET Making Ai chips for Foxo AI ??
      FOXO
      gp22 gp22 6 minutes ago
      $IVDA: Perfect play. R/S nano-float AI. Float already close to lock. Excellent company w/cash. Started getting found on Monday....Every reason to think IVDA is going to rip hard and fast. Load up in pre-market. Load up in pre-market.
      IVDA
      fishnman fishnman 6 minutes ago
      What the heck is going on
      CNNA
      penguin007 penguin007 6 minutes ago
      Even it takes time to prove financials, we'll most likely get a bounce on the announcement which is expected any week/day now.
      ZHUD
      gp22 gp22 7 minutes ago
      $IVDA: Perfect play. R/S nano-float AI. Float already close to lock. Excellent company w/cash. Started getting found on Monday....Every reason to think IVDA is going to rip hard and fast.
      IVDA
      MartinLutherKing MartinLutherKing 7 minutes ago
      Watch what happens with buy pressure brother
      FOXO
      AugustaFriends AugustaFriends 8 minutes ago
      $TRNR got in at .28 thanks Mark 😊
      TRNR
      mike_dotcom mike_dotcom 8 minutes ago
      No news today.
      AVXL
      meixatech meixatech 8 minutes ago
      As a scientist in this extremely competitive discipline, and if working with ampakine like CX-929, would I self-administer to improve my cognition? You bet! I have no doubt that off clinical trial application is occurring.
      RSPI
      Debunkinator Debunkinator 9 minutes ago
      $ASII had a great call with NASDAQ Nordic Specialist today!
      HUGE UPDATE NEXT, we’re just getting started
      #UPLIST #NORDIC
      9:48 AM · Sep 19, 2
      ASII
      Debunkinator Debunkinator 9 minutes ago
      $ASII had a great call with NASDAQ Nordic Specialist today!
      HUGE UPDATE NEXT, we’re just getting started
      #UPLIST #NORDIC
      9:48 AM · Sep 19, 2
      ASII
      TJG TJG 9 minutes ago
      He acknowledged the fact that this was the first time he has used the X Q&A service But he spoke for a hour explaining their business model and the plan they had to ensure its success
      PHBI
      penguin007 penguin007 9 minutes ago
      You do have a point...I guess I can see that side of it also.
      ZHUD
      Mark Mark 9 minutes ago
      $TRNR .47
      TRNR
      fuagf fuagf 9 minutes ago
      Try - Nope gone again. If anyone has idea on how to see the full Maddow - From Russia with Lev, please do.
      MartinLutherKing MartinLutherKing 9 minutes ago
      Nothing to laugh about brother, just get ready
      RNAZ
      Thomas@yahoo Thomas@yahoo 10 minutes ago
      Conclusion: This report provides evidence that using a CBD-rich extract was effective as a co-adjuvant in alleviating clinical signs of DM and concurrent disorders, allowing for the reduction of insulin intake.”
      https://karger.com/mca/article/doi/10.1159/000541034/913300/Use-of-cannabidiol-do
      CVSI
      neomania neomania 10 minutes ago
      Wizz and Photo said don't worry DEV has 2 techs working 24/7 in Colorado they got this. GO NSAV!!
      NSAV
      SoxFan SoxFan 11 minutes ago
      yup and with another disastrous season under our belt he will probably pass him this week. The only good thing is we found out we have some descent young players in Abreau, Rafaela, and Hamilton (no idea about Grissom as he was hurt all year). Fitts hopefully will be a undiscovered late season gem a
      VanLoot VanLoot 11 minutes ago
      The biggest tell is If an OTC stock can’t be shorted by retail traders, why do these bears live and die by discrediting AABB? For 3+ years now these “bears” have been here arguing everything under the sun. Why won’t they move on? If disgruntled about their investment, why not take the L and use it
      AABB
      tweedking tweedking 11 minutes ago
      Sierra Club


      NIMBY Karens pretending to be difference makers as climate activists when what they really want to protect is their property values.

      https://oilprice.com/Energy/Natural-Gas/US-LNG-Permit-Freeze-Sparks-Export-Boom-in-Canada-and-Mexico.html
      TGLO

      Your Recent History

      NASDAQ
      ERNA
      Eterna Therapeutics
      Delayed Upgrade Clock